Albertson Tina M. insider trades
Albertson Tina M. has filed 4 Form 4s with the SEC that we hold, for Caribou Biosciences, Inc. (CRBU) (Chief Medical Officer) and Lyell Immunopharma, Inc. (LYEL) (Chief Medical Officer). Across all of them we count 0 purchases worth $0 and 1 sale worth $2.1K reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($2.1K). The largest single trade was a sale of 1,066 shares of Caribou Biosciences, Inc. worth $2.1K, dated 2026-02-24. The first filing on our record is dated 2023-02-28 and the latest 2026-02-24.
Caribou Biosciences, Inc. (CRBU)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-02-24 | S, sale reported on Form 4 | 1,066 | $2.1K | 2026-02-24 |
Lyell Immunopharma, Inc. (LYEL)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1917391) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms